These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18436490)

  • 1. Transarterial embolization with microspheres in the treatment of monofocal HCC.
    Nicolini A; Fasani P; Manini MA; Martinetti L; Forzenigo LV; Iavarone M; Crespi S; Rossi G; Biondetti P; Colombo M; Sangiovanni A
    Dig Liver Dis; 2009 Feb; 41(2):143-9. PubMed ID: 18436490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A
    J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
    Shelgikar CS; Loehle J; Scoggins CR; McMasters KM; Martin RC
    J Surg Res; 2009 Jan; 151(1):121-4. PubMed ID: 18657833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
    Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
    Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
    Maluccio MA; Covey AM; Porat LB; Schubert J; Brody LA; Sofocleous CT; Getrajdman GI; Jarnagin W; Dematteo R; Blumgart LH; Fong Y; Brown KT
    J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
    Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
    Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of spontaneous rupture of hepatocellular carcinoma.
    Wang B; Lu Y; Zhang XF; Yú L; Pan CE; Wu Z
    ANZ J Surg; 2008 Jun; 78(6):501-3. PubMed ID: 18522574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma.
    Tsochatzis E; Garcovich M; Marelli L; Papastergiou V; Fatourou E; Rodriguez-Peralvarez ML; Germani G; Davies N; Yu D; Luong TV; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK
    Liver Int; 2013 Jul; 33(6):944-9. PubMed ID: 23530918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mode of response to chemotherapy for hepatocellular carcinoma induced by transarterial embolization. A case report.
    Okazaki N; Yoshida T; Yoshino M; Okada S; Shimada Y; Moriyama N; Takayasu K
    Jpn J Clin Oncol; 1991 Feb; 21(1):69-74. PubMed ID: 1648635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.
    Bruix J; Castells A; Montanyà X; Calvet X; Brú C; Ayuso C; Jover L; García L; Vilana R; Boix L
    Hepatology; 1994 Sep; 20(3):643-50. PubMed ID: 7521316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage.
    Huang YH; Chen CH; Chang TT; Chen SC; Chiang JH; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Huo TI; Lee SD; Wu JC
    Aliment Pharmacol Ther; 2005 Mar; 21(6):687-94. PubMed ID: 15771754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
    Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
    J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.